Orange Book product · Generic (ANDA)
SORAFENIB TOSYLATE
SORAFENIB TOSYLATE
Generic (ANDA)ANDA 207012TE ABRX MYLAN
At a glance
Sep 10, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 10, 2020
5 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
SORAFENIB TOSYLATE
Strength
EQ 200MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 207012
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SORAFENIB TOSYLATE
- 2005NEXAVARBrand (NDA)
NDA 021923 · BAYER HLTHCARE
- 2025SORAFENIB TOSYLATEGeneric (ANDA)
ANDA 212228 · APOTEX
- 2023SORAFENIB TOSYLATEGeneric (ANDA)
ANDA 217095 · TORRENT
- 2022SORAFENIB TOSYLATEGeneric (ANDA)
ANDA 209050 · YABAO PHARM
- 2022SORAFENIB TOSYLATEGeneric (ANDA)
ANDA 216073 · DR REDDYS
- 2020SORAFENIB TOSYLATEGeneric (ANDA)
ANDA 209567 · TEVA PHARMS USA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
